Dabigatran Etexilate Capsules 110 mg.......

Dabigatran Etexilate Capsules 110 mg
DABIGATREX 110  is an anticoagulant medication, and DABIGATREX 110  is commonly used to reduce the risk of stroke and blood clots in individuals with atrial fibrillation (an irregular heart rhythm) and to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).

DABIGATREX 110  is a direct thrombin inhibitor. DABIGATREX 110  is an enzyme involved in the blood clotting process. By inhibiting thrombin, dabigatran prevents the formation of blood clots.
DABIGATREX 110  is commonly prescribed to:
Reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).
Reduce the risk of recurrence of DVT and PE.

DABIGATREX 110  etexilate is typically taken orally as capsules. DABIGATREX 110  important to take the medication as prescribed, and it is often recommended to be taken with a full glass of water. The capsules should not be opened, crushed, or chewed.
DABIGATREX 110 monitoring of renal function is important as the excretion of dabigatran is primarily through the kidneys. Your healthcare provider may adjust the dose based on renal function.
DABIGATREX 110 side effects may include gastrointestinal symptoms such as dyspepsia (indigestion), gastritis, and gastrointestinal bleeding. As with any anticoagulant, there is a risk of bleeding, and severe bleeding can occur.
DABIGATREX 110  can interact with other medications, including those affecting renal function and other anticoagulants. DABIGATREX 110  important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and herbal supplements.
DABIGATREX 110  essential to take dabigatran etexilate exactly as prescribed by your healthcare provider. DABIGATREX 110 you have any concerns, questions, or experience side effects, it's crucial to discuss them with your healthcare provider for appropriate guidance. Regular follow-up appointments and monitoring are typically recommended to ensure the medication's effectiveness and to address any potential issues.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:https://www.sterisonline.com/product/dabigatrex-110-133287